1. Home
  2. MGF vs COEP Comparison

MGF vs COEP Comparison

Compare MGF & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Government Markets Income Trust

MGF

MFS Government Markets Income Trust

HOLD

Current Price

$2.85

Market Cap

95.2M

Sector

Finance

ML Signal

HOLD

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

HOLD

Current Price

$16.40

Market Cap

91.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGF
COEP
Founded
1987
2017
Country
United States
United States
Employees
N/A
6
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.2M
91.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MGF
COEP
Price
$2.85
$16.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
98.1K
92.3K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
7.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.82
$6.80
52 Week High
$3.14
$21.41

Technical Indicators

Market Signals
Indicator
MGF
COEP
Relative Strength Index (RSI) 39.60 72.18
Support Level N/A $13.77
Resistance Level $2.94 $19.19
Average True Range (ATR) 0.04 1.15
MACD -0.00 0.47
Stochastic Oscillator 25.00 87.62

Price Performance

Historical Comparison
MGF
COEP

About MGF MFS Government Markets Income Trust

MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.

Share on Social Networks: